Thymic stromal lymphopoietin-mediated extramedullary hematopoiesis promotes allergic inflammation. Academic Article uri icon

Overview

abstract

  • Extramedullary hematopoiesis (EMH) refers to the differentiation of hematopoietic stem cells (HSCs) into effector cells that occurs in compartments outside of the bone marrow. Previous studies linked pattern-recognition receptor (PRR)-expressing HSCs, EMH, and immune responses to microbial stimuli. However, whether EMH operates in broader immune contexts remains unknown. Here, we demonstrate a previously unrecognized role for thymic stromal lymphopoietin (TSLP) in promoting the population expansion of progenitor cells in the periphery and identify that TSLP-elicited progenitors differentiated into effector cells including macrophages, dendritic cells, and granulocytes and that these cells contributed to type 2 cytokine responses. The frequency of circulating progenitor cells was also increased in allergic patients with a gain-of-function polymorphism in TSLP, suggesting the TSLP-EMH pathway might operate in human disease. These data identify that TSLP-induced EMH contributes to the development of allergic inflammation and indicate that EMH is a conserved mechanism of innate immunity.

publication date

  • December 12, 2013

Research

keywords

  • Cytokines
  • Hematopoiesis, Extramedullary
  • Hypersensitivity
  • Inflammation
  • Spleen

Identity

PubMed Central ID

  • PMC3959827

Scopus Document Identifier

  • 84890150269

Digital Object Identifier (DOI)

  • 10.1016/j.immuni.2013.09.016

PubMed ID

  • 24332033

Additional Document Info

volume

  • 39

issue

  • 6